Zobrazeno 1 - 10
of 416
pro vyhledávání: '"Joep M A, Lange"'
Publikováno v:
PLoS Medicine, Vol 2, Iss 10, p e347 (2005)
Externí odkaz:
https://doaj.org/article/bc5eed59d27941ebb51a42c8cfb5e384
Autor:
Melissa Ditmore
Publikováno v:
PLoS Medicine, Vol 2, Iss 10, p e347 (2005)
Externí odkaz:
https://doaj.org/article/b49e18b99e434177bdda72231c0166cd
Autor:
Zuniga JM; Editor-in-Chief.
Publikováno v:
Journal of the International Association of Providers of AIDS Care [J Int Assoc Provid AIDS Care] 2014 Sep-Oct; Vol. 13 (5), pp. 392. Date of Electronic Publication: 2014 Aug 21.
Autor:
José M. Zuniga
Publikováno v:
Journal of the International Association of Providers of AIDS Care. 13(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3087ca016ae68c05a8977293f90198a2
https://pubmed.ncbi.nlm.nih.gov/25146973
https://pubmed.ncbi.nlm.nih.gov/25146973
Access the latest information available in the challenging area of HIV/AIDS management with Sande's HIV/AIDS Medicine, 2nd Edition. Authored by a veritable'who's who'of current global experts in the field, this medical reference book will provide you
Autor:
Ditmore M
Publikováno v:
PLoS medicine [PLoS Med] 2005 Oct; Vol. 2 (10), pp. e347. Date of Electronic Publication: 2005 Oct 25.
Autor:
Marlous L Grijsen, Ferdinand W N M Wit, Suzanne Jurriaans, Frank P Kroon, Emile F Schippers, Peter Koopmans, Luuk Gras, Joep M A Lange, Jan M Prins, Primo-SHM Study Group
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e89639 (2014)
Temporary cART during primary HIV-infection (PHI) did not select for drug resistance mutations after treatment interruption and did not affect the subsequent virological response to long-term cART. Our data demonstrate that fear of drug resistance de
Externí odkaz:
https://doaj.org/article/aa29d1b1c52a4b98a97ba1747b59e561
Autor:
Philippe R Mutwa, Kimberly R Boer, Brenda Asiimwe-Kateera, Diane Tuyishimire, Narcisse Muganga, Joep M A Lange, Janneke van de Wijgert, Anita Asiimwe, Peter Reiss, Sibyl P M Geelen
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e111948 (2014)
With increased availability of paediatric combination antiretroviral therapy (cART) in resource limited settings, cART outcomes and factors associated with outcomes should be assessed.HIV-infected children -2, immunological success as CD4 cells ≥50
Externí odkaz:
https://doaj.org/article/b1d6682bada54b06b31c018b8abc1811
Autor:
Natalie V S Vinkeles Melchers, Sabine L van Elsland, Joep M A Lange, Martien W Borgdorff, Jan van den Hombergh
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53644 (2013)
BACKGROUND: Prisoners are at high risk of developing tuberculosis (TB), causing morbidity and mortality. Prison facilities encounter many challenges in TB screening procedures and TB control. This review explores screening practices for detection of
Externí odkaz:
https://doaj.org/article/a4a6380eba24421fa3ec49eb6420d104
Autor:
Suzanne Jurriaans, Joep M. A. Lange, Ferdinand W. N. M. Wit, Stanley Luchters, Rolf W. Sparidans, Brigitte Kankindi, Jos H. Beijnen, Johan R. Boelaert, Nienke J. Veldhuijzen, Marloes A. Naarding, Matthew Chersich, Georgios Pollakis, Joseph Vyankandondera, Samuel Tuyizere, Rene A Douma, William A. Paxton
Chloroquine (CQ) and Hydroxychloroquine (HCQ) have been proposed to be effective at treating COVID-19 patients. We, and others, have previously reported on the capacity of CQ to reduce HIV-1 replication in vitro. We tested CQ administration in post-p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35eac8f79f31e606ac3f3db8a9a3dc5e
https://doi.org/10.1101/2020.04.29.20085308
https://doi.org/10.1101/2020.04.29.20085308